首页> 美国卫生研究院文献>Biochemical Journal >Purification of the hexokinases by affinity chromatography on sepharose-N-aminoacylglucosamine derivates. Design of affinity matrices from free solution kinetics.
【2h】

Purification of the hexokinases by affinity chromatography on sepharose-N-aminoacylglucosamine derivates. Design of affinity matrices from free solution kinetics.

机译:通过在琼脂糖-N-氨基酰基葡糖胺衍生物上的亲和色谱法纯化己糖激酶。从自由溶液动力学设计亲和矩阵。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purification is described of rat hepatic hexokinase type III and kidney hexokinase type I on a large scale by using a combination of conventional and affinity techniques similar to those previously used for the purification of rat hepatic glucokinase [Holroyde, Allen, Storer, Warsy, Chesher, Trayer, Cornish-Bowden & Walker (1976) Biochem. J. 153, 363-373] and muscle hexokinase type II [Holroyde & Trayer (1976) FEBS Lett. 62, 215-219]. The key to each purification was the use of a Sepharose-N-aminoacylglucosamine affinity matrix in which a high degree of specificity for a particular hexokinase isoenzyme could be introduced by either varying the length of the aminoacyl spacer and/or varying the ligand concentration coupled to the gel. This was predicted from a study of the free solution kinetic properties of the various N-aminoacylglucosamine derivatives used (N-aminopropionyl, N-aminobutyryl, N-aminohexanoyl and N-aminooctanoyl), synthesized as described by Holroyde, Chesher, Trayer & Walker [(1976) Biochem. J. 153, 351-361]. All derivatives were competitive inhibitors, with respect to glucose, of the hexokinase reaction, and there was a direct correlation between the Ki for a particular derivative and its ability to act as an affinity matrix when immobilized to CNBr-activated Sepharose 4B. Muscle hexokinase type II could be chromatographed on the Sepharose conjugates of all four N-aminoacylglucosamine derivatives, although the N-aminohexanoylglucosamine derivative proved best. This same derivative was readily able to bind hepatic glucokinase and hexokinase type III, but Sepharose-N-amino-octanoyl-glucosamine was better for these enzymes and was the only derivative capable of binding kidney hexokinase type I efficiently. Separate studies with yeast hexokinase showed that again only the Sepharose-N-amino-octanoylglucosamine was capable of acting as an efficient affinity matrix for this enzyme. Implications of these studies in our understanding of affinity-chromatography operation are discussed.
机译:通过使用常规和亲和技术的组合(与以前用于纯化大鼠肝葡萄糖激酶的技术类似)[Holroyde,Allen,Storer,Warsy,Chesher进行了组合],大规模地描述了III型大鼠肝己糖激酶和I型肾脏己糖激酶的纯化,Trayer,Cornish-Bowden&Walker(1976)生物化学。 J. 153,363-373]和II型肌肉己糖激酶[Holroyde&Trayer(1976)FEBS Lett。 62,215-219]。每次纯化的关键是使用琼脂糖-N-氨基酰基葡糖胺亲和基质,其中可以通过改变氨酰基间隔基的长度和/或改变与之偶联的配体浓度来引入对特定己糖激酶同工酶的高度特异性。凝胶。这是根据对所用的各种N-氨基酰基氨基葡萄糖衍生物(N-氨基丙酰基,N-氨基丁酰基,N-氨基己酰基和N-氨基辛酰基)的自由溶液动力学性质的研究预测的,该衍生物是按Holroyde,Chesher,Trayer和Walker的描述合成的[ (1976)生物化学。 J. 153,351-361]。就葡萄糖而言,所有衍生物都是己糖激酶反应的竞争性抑制剂,特定衍生物的Ki与固定在CNBr活化的Sepharose 4B上作为亲和基质的能力之间存在直接相关性。 II型肌肉己糖激酶可以在所有四种N-氨基酰基氨基葡萄糖衍生物的Sepharose缀合物上进行色谱分离,尽管N-氨基己酰基氨基葡萄糖衍生物被证明是最好的。这种相同的衍生物很容易结合肝糖激酶和III型己糖激酶,但是琼脂糖-N-氨基-辛酰基-葡糖胺对这些酶更好,并且是唯一能够有效结合I型肾脏己糖酶的衍生物。酵母己糖激酶的单独研究表明,只有琼脂糖-N-氨基-辛酰基葡糖胺能够充当该酶的有效亲和基质。讨论了这些研究对我们对亲和色谱操作的理解的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号